{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:57:51Z","timestamp":1790067471289,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T00:00:00Z","timestamp":1394496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1038\/mp.2014.17","type":"journal-article","created":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T09:06:02Z","timestamp":1394528762000},"page":"252-262","source":"Crossref","is-referenced-by-count":95,"title":["Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"20","author":[{"given":"H","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Wallack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4952-1734","authenticated-orcid":false,"given":"H","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Carreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Dedeoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-Y","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Fine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mwamburi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Kowall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Q","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,11]]},"reference":[{"key":"BFmp201417_CR1","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0196-9781(98)00018-7","volume":"19","author":"WA Banks","year":"1998","unstructured":"Banks WA, Kastin AJ . Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin. Peptides 1998; 19: 883\u2013889.","journal-title":"Peptides"},{"key":"BFmp201417_CR2","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.peptides.2007.06.011","volume":"28","author":"M Olsson","year":"2007","unstructured":"Olsson M, Herrington MK, Reidelberger RD, Permert J, Arnelo U . Comparison of the effects of chronic central administration and chronic peripheral administration of islet amyloid polypeptide on food intake and meal pattern in the rat. Peptides 2007; 28: 1416\u20131423.","journal-title":"Peptides"},{"key":"BFmp201417_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/MED.0b013e32835b896f","volume":"20","author":"JD Roth","year":"2013","unstructured":"Roth JD, Roth JD, Erickson MR, Chen S, Parkes DG . Amylin and the regulation of appetite and adiposity: recent advances in receptor signaling, neurobiology and pharmacology GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities. Curr Opin Endocrinol Diabetes Obes 2013; 20: 8\u201313.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"BFmp201417_CR4","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1097\/00005344-199512000-00012","volume":"26","author":"TC Westfall","year":"1995","unstructured":"Westfall TC, Curfman-Falvey M . Amylin-induced relaxation of the perfused mesenteric arterial bed: meditation by calcitonin gene-related peptide receptors. J Cardiovasc Pharmacol 1995; 26: 932\u2013936.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFmp201417_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1100\/tsw.2001.23","volume":"1","author":"L Edvinsson","year":"2001","unstructured":"Edvinsson L, Goadsby PJ, Uddman R . Amylin: localization, effects on cerebral arteries and on local cerebral blood flow in the cat. ScientificWorldJournal 2001; 1: 168\u2013180.","journal-title":"ScientificWorldJournal"},{"key":"BFmp201417_CR6","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.1210\/en.2010-0590","volume":"151","author":"JL Trevaskis","year":"2010","unstructured":"Trevaskis JL, Turek VF, Wittmer C, Griffin PS, Wilson JK, Reynolds JM et al. Enhanced amylin-mediated body weight loss in estradiol-deficient diet-induced obese rats. Endocrinology 2010; 151: 5657\u20135668.","journal-title":"Endocrinology"},{"key":"BFmp201417_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/826706","volume":"826706","author":"K Pillay","year":"2013","unstructured":"Pillay K, Govender P . Amylin uncovered: a review on the polypeptide responsible for type II diabetes. Biomed Res Int 2013; 826706: 1\u201317.","journal-title":"Biomed Res Int"},{"key":"BFmp201417_CR8","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1007\/s00125-010-1671-6","volume":"53","author":"S Zraika","year":"2010","unstructured":"Zraika S, Hull RL, Verchere CB, Clark A, Potter KJ, Fraser PE et al. Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence? Diabetologia 2010; 53: 1046\u20131056.","journal-title":"Diabetologia"},{"key":"BFmp201417_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2147\/VHRM.S1978","volume":"4","author":"BJ Hoogwerf","year":"2008","unstructured":"Hoogwerf BJ, Doshi KB, Diab D . Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk. Vasc Health Risk Manag 2008; 4: 355\u2013362.","journal-title":"Vasc Health Risk Manag"},{"key":"BFmp201417_CR10","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.febslet.2008.05.006","volume":"582","author":"YA Lim","year":"2008","unstructured":"Lim YA, Ittner LM, Lim YL, Gotz J . Human but not rat amylin shares neurotoxic properties with Abeta42 in long-term hippocampal and cortical cultures. FEBS Lett 2008; 582: 2188\u20132194.","journal-title":"FEBS Lett"},{"key":"BFmp201417_CR11","doi-asserted-by":"publisher","first-page":"18820","DOI":"10.1074\/jbc.M111.331181","volume":"287","author":"W Fu","year":"2012","unstructured":"Fu W, Ruangkittisakul A, MacTavish D, Shi JY, Ballanyi K, Jhamandas JH et al. Amyloid beta (Abeta) peptide directly activates amylin-3 receptor subtype by triggering multiple intracellular signaling pathways. J Biol Chem 2012; 287: 18820\u201318830.","journal-title":"J Biol Chem"},{"key":"BFmp201417_CR12","doi-asserted-by":"publisher","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","volume":"273","author":"Q Qiu, W","year":"1998","unstructured":"Qiu, W Q, Walsh DM, Ye Z, Vekrellis K, Zhang J, Podlisny MB et al. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degra dation. J Biol Chem 1998; 273: 32730\u201332738.","journal-title":"J Biol Chem"},{"key":"BFmp201417_CR13","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.2337\/diabetes.52.9.2315","volume":"52","author":"RG Bennett","year":"2003","unstructured":"Bennett RG, Hamel FG, Duckworth WC . An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures. Diabetes 2003; 52: 2315\u20132320.","journal-title":"Diabetes"},{"key":"BFmp201417_CR14","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nature05143","volume":"443","author":"Y Shen","year":"2006","unstructured":"Shen Y, Joachimiak A, Rosner MR, Tang WJ . Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature 2006; 443: 870\u2013874.","journal-title":"Nature"},{"key":"BFmp201417_CR15","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/anie.200604056","volume":"46","author":"LM Yan","year":"2007","unstructured":"Yan LM, Velkova A, Tatarek-Nossol M, Andreetto E, Kapurniotu A . IAPP mimic blocks Abeta cytotoxic self-assembly: cross-suppression of amyloid toxicity of Abeta and IAPP suggests a molecular link between Alzheimer's disease and type II diabetes. Angew Chem Int Ed Engl 2007; 46: 1246\u20131252.","journal-title":"Angew Chem Int Ed Engl"},{"key":"BFmp201417_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bpc.2010.01.006","volume":"150","author":"D Sellin","year":"2010","unstructured":"Sellin D, Yan LM, Kapurniotu A, Winter R . Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin. Biophys Chem 2010; 150: 73\u201379.","journal-title":"Biophys Chem"},{"key":"BFmp201417_CR17","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/cbic.201100192","volume":"12","author":"E Andreetto","year":"2011","unstructured":"Andreetto E, Yan LM, Caporale A, Kapurniotu A . Dissecting the role of single regions of an IAPP mimic and IAPP in inhibition of Abeta40 amyloid formation and cytotoxicity. Chembiochem 2011; 12: 1313\u20131322.","journal-title":"Chembiochem"},{"key":"BFmp201417_CR18","doi-asserted-by":"crossref","unstructured":"Yan LM, Velkova A, Kapurniotu A . Molecular characterization of the hetero-assembly of beta-amyloid peptide with islet amyloid polypeptide. Curr Pharm Des 2013 (e-pub ahead of print).","DOI":"10.2174\/13816128113199990064"},{"key":"BFmp201417_CR19","doi-asserted-by":"publisher","first-page":"10378","DOI":"10.1002\/anie.201302840","volume":"52","author":"LM Yan","year":"2013","unstructured":"Yan LM, Velkova A, Tatarek-Nossol M, Rammes G, Sibaev A, Andreetto E et al. Selectively N-methylated soluble IAPP mimics as potent IAPP receptor agonists and nanomolar inhibitors of cytotoxic self-assembly of both IAPP and Abeta40. Angew Chem Int Ed Engl 2013; 52: 10378\u201310383.","journal-title":"Angew Chem Int Ed Engl"},{"key":"BFmp201417_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.23956","volume":"74","author":"K Jackson","year":"2013","unstructured":"Jackson K, Barisone GA, Diaz E, Jin LW, DeCarli C, Despa F et al. Amylin deposition in the brain: a second amyloid in Alzheimer disease? Ann Neurol 2013; 74: 517\u2013526.","journal-title":"Ann Neurol"},{"key":"BFmp201417_CR21","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci 2006; 26: 10129\u201310140.","journal-title":"J Neurosci"},{"key":"BFmp201417_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao K, Ueberham U, Br\u00fcckner MK, Seeger G, Arendt T, G\u00e4rtner U et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996; 274: 99\u2013102.","journal-title":"Science"},{"key":"BFmp201417_CR23","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1126\/science.1971458","volume":"248","author":"C Van Broeckhoven","year":"1990","unstructured":"Van Broeckhoven C, Haan J, Bakker E, Hardy JA, Van Hul W, Wehnert A et al Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science 1990; 248: 1120\u20131122.","journal-title":"Science"},{"key":"BFmp201417_CR24","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1073\/pnas.0813314106","volume":"106","author":"H Zhu","year":"2009","unstructured":"Zhu H, Acquaviva J, Ramachandran P, Boskovitz A, Woolfenden S, Pfannl R et al. Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis. Proc Natl Acad Sci USA 2009; 106: 2712\u20132716.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp201417_CR25","doi-asserted-by":"publisher","first-page":"41774","DOI":"10.1074\/jbc.M112.407957","volume":"287","author":"KL Youmans","year":"2012","unstructured":"Youmans KL, Tai LM, Nwabuisi-Heath E, Jungbauer L, Kanekiyo T, Gan M et al. APOE4-specific changes in Abeta accumulation in a new transgenic mouse model of Alzheimer disease. J Biol Chem 2012; 287: 41774\u201341786.","journal-title":"J Biol Chem"},{"key":"BFmp201417_CR26","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/gps.1762","volume":"22","author":"WQ Qiu","year":"2007","unstructured":"Qiu WQ, Summergrad P, Folstein M . Plasma Abeta42 levels and depression in the elderly. Int J Geriatr Psychiatry 2007; 22: 930.","journal-title":"Int J Geriatr Psychiatry"},{"key":"BFmp201417_CR27","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1001\/archpsyc.65.5.542","volume":"65","author":"X Sun","year":"2008","unstructured":"Sun X, Steffens DC, Au R, Folstein M, Summergrad P, Yee J et al. Amyloid-associated depression: a prodromal depression of Alzheimer disease? Arch Gen Psychiatry 2008; 65: 542\u2013550.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp201417_CR28","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/35050110","volume":"408","author":"C Janus","year":"2000","unstructured":"Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD et al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease transgenic mouse models of Alzheimer's disease. Nature 2000; 408: 979\u2013982.","journal-title":"Nature"},{"key":"BFmp201417_CR29","doi-asserted-by":"publisher","first-page":"6117","DOI":"10.1021\/jm049388p","volume":"47","author":"CA Coburn","year":"2004","unstructured":"Coburn CA, Stachel SJ, Li YM Rush DM, Steele TG, Chen-Dodson E et al. Identification of a small molecule nonpeptide active site beta-secretase inhibitor that displays a nontraditional binding mode for aspartyl proteases. J Med Chem 2004; 47: 6117\u20136119.","journal-title":"J Med Chem"},{"key":"BFmp201417_CR30","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939\u2013944.","journal-title":"Neurology"},{"key":"BFmp201417_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1001\/archneur.56.3.303","volume":"56","author":"RC Petersen","year":"1999","unstructured":"Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303\u2013308.","journal-title":"Arch Neurol"},{"key":"BFmp201417_CR32","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1046\/j.0022-3042.2002.00806.x","volume":"80","author":"F Fischer","year":"2002","unstructured":"Fischer F, Molinari M, Bodendorf U, Paganetti P . The disulphide bonds in the catalytic domain of BACE are critical but not essential for amyloid precursor protein processing activity. J Neurochem 2002; 80: 1079\u20131088.","journal-title":"J Neurochem"},{"key":"BFmp201417_CR33","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.286.5440.735","volume":"286","author":"R Vassar","year":"1999","unstructured":"Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999; 286: 735\u2013741.","journal-title":"Science"},{"key":"BFmp201417_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/990107","volume":"402","author":"R Yan","year":"1999","unstructured":"Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM et al. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 1999; 402: 533\u2013537.","journal-title":"Nature"},{"key":"BFmp201417_CR35","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/gps.2568","volume":"26","author":"X Sun","year":"2011","unstructured":"Sun X, Bhadelia R, Liebson E, Bergethon P, Folstein M, Zhu JJ et al. The relationship between plasma amyloid-beta peptides and the medial temporal lobe in the homebound elderly. Int J Geriatr Psychiatry 2011; 26: 593\u2013601.","journal-title":"Int J Geriatr Psychiatry"},{"key":"BFmp201417_CR36","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 2008; 14: 837\u2013842.","journal-title":"Nat Med"},{"key":"BFmp201417_CR37","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.cell.2009.11.014","volume":"139","author":"E Cohen","year":"2009","unstructured":"Cohen E, Paulsson JF, Blinder P, Burstyn-Cohen T, Du D, Estepa G et al. Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. Cell 2009; 139: 1157\u20131169.","journal-title":"Cell"},{"key":"BFmp201417_CR38","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1073\/pnas.0608332104","volume":"104","author":"J Shen","year":"2007","unstructured":"Shen J, Kelleher RJ 3rd . The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism. Proc Natl Acad Sci USA 2007; 104: 403\u2013409.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp201417_CR39","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1210951","volume":"369","author":"RS Doody","year":"2013","unstructured":"Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S et al. A phase 3 trial of semagacestat for treatment of Alzheimer's disease. N Engl J Med 2013; 369: 341\u2013350.","journal-title":"N Engl J Med"},{"key":"BFmp201417_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a011452","volume":"2","author":"AP Sagare","year":"2012","unstructured":"Sagare AP, Bell RD, Zlokovic BV . Neurovascular dysfunction and faulty amyloid beta-peptide clearance in Alzheimer disease. Cold Spring Harb Perspect Med 2012; 2: 1\u201317.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"BFmp201417_CR41","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1126\/science.1067568","volume":"295","author":"RB DeMattos","year":"2002","unstructured":"DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM . Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 2002; 295: 2264\u20132267.","journal-title":"Science"},{"key":"BFmp201417_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/WNF.0b013e31823a13d3","volume":"35","author":"K Uenaka","year":"2012","unstructured":"Uenaka K, Nakano M, Willis BA, Friedrich S, Ferguson-Sells L, Dean RA et al. Comparison of pharmacokinetics, pharmacodynamics, safety, and tolerability of the amyloid beta monoclonal antibody solanezumab in Japanese and white patients with mild to moderate alzheimer disease. Clin Neuropharmacol 2012; 35: 25\u201329.","journal-title":"Clin Neuropharmacol"},{"key":"BFmp201417_CR43","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/85059","volume":"4","author":"Y Luo","year":"2001","unstructured":"Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P et al. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat Neurosci 2001; 4: 231\u2013232.","journal-title":"Nat Neurosci"},{"key":"BFmp201417_CR44","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1093\/hmg\/10.12.1317","volume":"10","author":"SL Roberds","year":"2001","unstructured":"Roberds SL, Anderson J, Basi G, Bienkowski MJ, Branstetter DG, Chen KS et al. BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum Mol Genet 2001; 10: 1317\u20131324.","journal-title":"Hum Mol Genet"},{"key":"BFmp201417_CR45","doi-asserted-by":"publisher","first-page":"12787","DOI":"10.1523\/JNEUROSCI.3657-09.2009","volume":"29","author":"R Vassar","year":"2009","unstructured":"Vassar R, Kovacs DM, Yan R, Wong PC . The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential. J Neurosci 2009; 29: 12787\u201312794.","journal-title":"J Neurosci"},{"key":"BFmp201417_CR46","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/j.1471-4159.2006.04260.x","volume":"100","author":"I Hussain","year":"2007","unstructured":"Hussain I, Hawkins J, Harrison D, Hille C, Wayne G, Cutler L et al. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo. J Neurochem 2007; 100: 802\u2013809.","journal-title":"J Neurochem"},{"key":"BFmp201417_CR47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0079-6468(09)04804-8","volume":"48","author":"JS Albert","year":"2009","unstructured":"Albert JS . Progress in the development of beta-secretase inhibitors for Alzheimer's disease. Prog Med Chem 2009; 48: 133\u2013161.","journal-title":"Prog Med Chem"},{"key":"BFmp201417_CR48","doi-asserted-by":"publisher","first-page":"a006213","DOI":"10.1101\/cshperspect.a006213","volume":"2","author":"KA Johnson","year":"2012","unstructured":"Johnson KA, Fox NC, Sperling RA, Klunk WE . Brain imaging in Alzheimer disease. Cold Spring Harb Perspect Med 2012; 2: a006213.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"BFmp201417_CR49","doi-asserted-by":"publisher","first-page":"S233","DOI":"10.2337\/diabetes.53.suppl_3.S233","volume":"53","author":"O Schmitz","year":"2004","unstructured":"Schmitz O, Brock B, Rungby J . Amylin agonists: a novel approach in the treatment of diabetes. Diabetes 2004; 53: S233\u2013S238.","journal-title":"Diabetes"},{"key":"BFmp201417_CR50","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1365-2125.2011.04134.x","volume":"73","author":"S Salomone","year":"2012","unstructured":"Salomone S, Caraci F, Leggio GM, Fedotova J, Drago F . New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs. Br J Clin Pharmacol 2012; 73: 504\u2013517.","journal-title":"Br J Clin Pharmacol"},{"key":"BFmp201417_CR51","doi-asserted-by":"publisher","first-page":"G762","DOI":"10.1152\/ajpgi.00476.2011","volume":"302","author":"JL Trevaskis","year":"2012","unstructured":"Trevaskis JL, Griffin PS, Wittmer C, Neuschwander-Tetri BA, Brunt EM, Dolman CS et al. Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice. Am J Physiol Gastrointest Liver Physiol 2012; 302: G762\u2013G772.","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/mp201417.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp201417","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp201417.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:14:57Z","timestamp":1684433697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp201417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,11]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["BFmp201417"],"URL":"https:\/\/doi.org\/10.1038\/mp.2014.17","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,11]]}}}